FOXP3 and cancer: Celastrol reportedly directly suppresses T-cell proliferation and Th17 cell induction, while facilitating forkhead box P3 (Foxp3) expression and Treg cell proliferation, indicating an immune suppression phenotype in cancer (Astry et al., 2015; Zhang et al., 2018).